^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SAR566658

    i
    Other names: SAR566658, huDS6-DM4, ACT14884
    Company:
    AbbVie, Sanofi
    Drug class:
    Microtubule inhibitor, CA6-targeted antibody-drug conjugate
    Related drugs:
    almost4years
    An antibody drug conjugate targeting MUC1 associated carbohydrate CA6, shows promising anti-tumor activities. (PubMed, Mol Cancer Ther)
    SAR566658 displayed better efficacy than standard of care non-targeted tubulin binders. This data supports the development of SAR566658 in patients with CA6 expressing tumors.
    Journal
    |
    MUC1 (Mucin 1)
    |
    SAR566658